BIOMED REALTY TRUST INC
BMR
BMR was delisted on the 27th of January, 2016.
4 hedge funds and large institutions have $30.4M invested in BIOMED REALTY TRUST INC in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 285 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
99% less funds holding
Funds holding: 290 → 4 (-286)
99% less capital invested
Capital invested by funds: $4.36B → $30.4M (-$4.33B)
100% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 285
100% less funds holding in top 10
Funds holding in top 10: 11 → 0 (-11)
Top Buyers
| 1 |
MAM
Mizuho Asset Management
Tokyo,
Japan
|
+$893K |
| 2 |
HNB
Huntington National Bank
Columbus,
Ohio
|
+$4.86K |
| 3 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$24 |
Top Sellers
BMR Hedge Fund Activity: Q1 2016 in Review
4 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BIOMED REALTY TRUST INC (BMR) for Q1 2016, worth a combined $30.4M — down 99% from $4.36B a quarter earlier.
Sellers outnumbered buyers: 285 funds closed out of BMR and 1 opened new positions — a net loss of 284 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Mizuho Asset Management, opening a new position worth an estimated $893K. The largest seller was Vanguard Group, exiting entirely with an estimated $695M sold.
- 4 institutional investors held BIOMED REALTY TRUST INC (BMR) as of Q1 2016, down from 290 in Q4 2015.
- Funds reported $30.4M of BIOMED REALTY TRUST INC stock for Q1 2016, down 99% quarter-over-quarter.
- 1 fund opened new BIOMED REALTY TRUST INC positions in Q1 2016 and 285 closed out, a net change of -284 holders.
- The largest BIOMED REALTY TRUST INC buyer in Q1 2016 was Mizuho Asset Management, an estimated $893K added.
- The largest BIOMED REALTY TRUST INC seller in Q1 2016 was Vanguard Group, an estimated $695M sold.
Based on aggregated 13F filings for Q1 2016.